Thursday, 24 December 2009

Former head of CDC lands lucrative job as president of Merck vaccine division

You've heard it before, how the pharmaceutical industry has a giant "revolving door" through which corporations and government agencies frequently exchange key employees. That reality was driven home in a huge way today when news broke that Dr. Julie Gerberding, who headed the CDC from 2002 through 2009, landed a top job with Merck, one of the largest drug companies in the world. Her job there? She's the new president of the vaccine division.

How convenient. That means the former head of the CDC was very likely cultivating a relationship with Merck all these years, and now comes the big payoff: Heading up a $5 billion division that sells cervical cancer vaccines (like Gardasil), chickenpox vaccines and of course H1N1 swine flu vaccines, too.
You might even say that the CDC already functions as the marketing division of the pharmaceutical industry. It was the CDC that pushed so hard for swine flu vaccines, even amid the obvious realization that swine flu was no more dangerous than seasonal flu.

The worse thing about the recent push for swine flu vaccinations is that many companies have chosen to use toxic preservatives such as the mercury based Thimerosal.

There seems to be no good reason to use such heavy metals. It should be the job of Government health authorities to make sure these substances are banned from any vaccine shots.

[Posted at the SpookyWeather blog, December 24th, 2009.]


mgyerman said...

Yes, this is interesting indeed. Tweeted the Reuters story. As a writer covering the Gardasil story, I find this most disturbing.

SpookyPunkos said...

Thanks mgyerman,

If you click on the "medicine" tag at this blog you will find other stories dealing with the vaccine issue. I have not covered the Gardasil story.

For a better source of such news I highly recommend visiting That news site hoovers up many more stories on health and medicine than I can deal with here !

I'd click on their health tag for more sources.